Newland Pharmaceutical Hits Day High with 10.84% Surge in Stock Price

Newland Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 10.84% on July 13, 2026. The stock reached an intraday high of CNY 11.17, marking a notable achievement in a challenging market environment. In comparison, the China Shanghai Composite index declined by 2.06% on the same day, highlighting Newland's relative strength. Over the past week, Newland has shown a robust performance with a 13.6% increase, and its one-month performance stands at 17.63%. However, the company has faced difficulties over the longer term, with a one-year decline of 25.07% and a three-year drop of 44.13%. Despite these challenges, the stock's recent activity indicates a moment of resilience. Key financial metrics reveal a market capitalization of CNY 669 million and a price-to-earnings ratio of 7.00. The company's return on equity is recorded at 6.18%, while its debt-equity ratio stands at -0.42. These figures provide insight into Newland's current market position within the pharmaceuticals and biotechnology sector.